Rochal Industries

Rochal Industries is a private, Texas-based medtech firm with a long history of innovation in polymer science for healthcare, notably pioneering non-stinging liquid bandages. Its core focus is on developing transformative products for chronic wound management and surgical site infection prevention, driven by a proprietary technology platform in biomaterials and synergistic antimicrobials. The company has transitioned key products to commercial partner Sanara MedTech Inc. and is backed by private equity firm The Catalyst Group, which supports the growth of its preclinical and clinical pipeline. Rochal's strategy combines internal R&D with strategic partnerships to address significant unmet clinical needs in wound care.

Integrated platform leveraging expertise in natural/synthetic polymers, synergistic antimicrobials, and flowable biological systems to create advanced wound care and skin health products.

Rochal competes in the advanced wound care market against large players like 3M, Smith & Nephew, and Mölnlycke, as well as specialized biotech firms. Its differentiation lies in its deep polymer science heritage and synergistic approach to antimicrobial action, but it must overcome the commercial scale and brand recognition of incumbents.